Hydralazine
Related Subjects:
|Hypertension
|Acute Heart Failure
|Chronic Heart Failure
โ ๏ธ Slow acetylators are at greater risk of hydralazine toxicity.
๐ก In these patients, adverse effects such as profound hypotension or a lupus-like syndrome are more common.
- ๐น Potent arterial vasodilator.
- ๐ Causes reflex tachycardia and increased cardiac output.
โ๏ธ Mode of Action
- ๐งช Direct vascular smooth muscle relaxant.
- โฌ๏ธ Increases intracellular cGMP, enhancing nitric oxideโmediated vasodilation.
- ๐ Lowers afterload, useful in resistant hypertension and heart failure (when combined with nitrates).
๐ฏ Indications
- ๐ Congestive cardiac failure (CCF) โ usually in combination with nitrates (e.g. hydralazine + isosorbide dinitrate in HFrEF, esp. in Afro-Caribbean patients per NICE/ESC guidelines).
- ๐ Severe or resistant hypertension (not first-line).
- ๐คฐ Hypertension in pregnancy (can be used IV in pre-eclampsia emergencies).
๐ Dose (BNF guidance โ check individualisation)
- โก๏ธ Oral: 25 mg PO BD, titrate up to 50 mg BD.
- โก๏ธ IV (acute use): 5โ10 mg slow IV in normal saline (may repeat as needed under close monitoring).
๐ Interactions
- โฌ๏ธ Additive hypotension with other antihypertensives, nitrates, or alcohol.
- โ ๏ธ May potentiate reflex tachycardia if used with vasodilators.
โ Contraindications
- โ ๏ธ Ischaemic heart disease โ can worsen angina due to reflex tachycardia.
- ๐ซ Severe tachycardia or high-output states.
โ ๏ธ Side Effects
- โค๏ธ Reflex tachycardia (often requires co-administration of a beta-blocker).
- ๐ฆ Drug-induced lupus-like syndrome (check ANA, monitor urine for proteinuria) โ risk higher with prolonged use, high doses, and in slow acetylators.
- ๐ค Headache, dizziness, flushing.
- ๐ Postural hypotension.
- ๐ฉ Diarrhoea, GI upset.
๐ References